DAFRA Pharma Nig

DAFRA is an independent Belgian pharmaceutical company located in Turnhout, Belgium, specialized in: Contract Production of pharmaceutical raw materials. Contract Production and distribution of pharmaceutical specialities. Contract Production of Artemisinin Combination Therapies (ACT: recommended by WHO ) Dafra Pharma is specialized in R&D and implements c-EU.GMP rules on production sites, regularly audited by Dafra Pharma QA Staff. REALS entered into a partnership with DAFRA in 2006 and is responsible for the marketing and promotion of their high quality Antimalarial products Arinate, Co-Arinate, Co-artesiane susp and Artesiane in its Tablet, Injectables and Syrup presentations. DAFRA Pharma Nig. has competent and dedicated medical representatives that promotes, detail and ensures the availability of all DAFRA Antimalarial ranges all over the Federation. Send an email to dafrapharmanig@realsgroup.com for more information. DAFRA Pharma Nig markets the following products. Co- Arinate Tabs , an artesunate based combination therapy which contains artesunate and sulphamethoxy  pyrazine/pyrimethamine, each of which is active against Malaria parasites. It comes in two presentations, adult and Junior. Co- Artesiane Suspension containing Artemether and Lumefantrine in a dry powder mixture for making up a suspension with water. Especially designed for treating malaria in Children of up to 5 years old. Arinate Tabs (in 2 strengths, 50mg and 100mg) Box of 6 blister packed scored tablets containing Artesunate for the curative treatment of all forms of plasmodium including severe malaria caused by Multiple drug resistant strains of P. falciparum. Artesiane Artemether presented as Injectables (20mg/ml and 80mg/ml) and Suppositories (40mg suppogel).